Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice-Reference-Cited by-同舟云学术

Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice

Published:2014-05-06 Issue:5 Volume:9 Page:e96147
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hong Yu Ah,Lim Ji Hee,Kim Min Young,Kim Tae Woo,Kim Yaeni,Yang Keun Suk,Park Hoon Suk,Choi Sun Ryoung,Chung Sungjin,Kim Hyung Wook,Kim Hye Won,Choi Bum Soon,Chang Yoon Sik,Park Cheol Whee

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. New pharmacological treatments for improving renal outcomes in diabetes;AE Decleves;Nat Rev Nephrol,2010

2. Pathogenetic mechanisms of diabetic nephropathy;FP Schena;J Am Soc Nephrol,2005

3. AGE, RAGE, and ROS in diabetic nephropathy;AL Tan;Semin Nephrol,2007

4. Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation;M Murea;Clin J Am Soc Nephrol,2010

5. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease;JF Moorhead;Lancet,1982

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrato atenua a lipotoxicidade renal em camundongos uninefrectomizados com obesidade induzida por dieta rica em gordura;Brazilian Journal of Nephrology;2024-12

2. Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity;Brazilian Journal of Nephrology;2024-12

3. Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy;Biochemical Pharmacology;2024-11

4. Clinical characteristics and treatment compounds of obesity-related kidney injury;World Journal of Diabetes;2024-06-15

5. Crosstalk interactions between transcription factors ERRα and PPARα assist PPARα-mediated gene expression;Molecular Metabolism;2024-06